AU1801899A - Small peptides and methods for treatment of asthma and inflammation - Google Patents

Small peptides and methods for treatment of asthma and inflammation Download PDF

Info

Publication number
AU1801899A
AU1801899A AU18018/99A AU1801899A AU1801899A AU 1801899 A AU1801899 A AU 1801899A AU 18018/99 A AU18018/99 A AU 18018/99A AU 1801899 A AU1801899 A AU 1801899A AU 1801899 A AU1801899 A AU 1801899A
Authority
AU
Australia
Prior art keywords
phe
tyr
group
peptide
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18018/99A
Other languages
English (en)
Inventor
James Clagett
John C. Houck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Histatek LLC
Original Assignee
Histatek LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Histatek LLC filed Critical Histatek LLC
Publication of AU1801899A publication Critical patent/AU1801899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU18018/99A 1998-12-03 1998-12-03 Small peptides and methods for treatment of asthma and inflammation Abandoned AU1801899A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/025583 WO2000032217A1 (en) 1998-12-03 1998-12-03 Small peptides and methods for treatment of asthma and inflammation

Publications (1)

Publication Number Publication Date
AU1801899A true AU1801899A (en) 2000-06-19

Family

ID=22268409

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18018/99A Abandoned AU1801899A (en) 1998-12-03 1998-12-03 Small peptides and methods for treatment of asthma and inflammation

Country Status (10)

Country Link
EP (1) EP1152770A1 (pt)
JP (1) JP2003504304A (pt)
KR (1) KR100596136B1 (pt)
CN (1) CN1341026A (pt)
AU (1) AU1801899A (pt)
BR (1) BR9816097A (pt)
CA (1) CA2353550A1 (pt)
HK (1) HK1044468A1 (pt)
MX (1) MXPA01005600A (pt)
WO (1) WO2000032217A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2309639C (en) 1997-11-13 2010-03-23 John C. Houck Small peptides and methods for treatment of asthma and inflammation
CN1367700A (zh) * 1999-07-16 2002-09-04 海斯塔泰克有限责任公司 用于下调lgE的小肽和方法
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US9788821B2 (en) 2005-04-29 2017-10-17 Cook Biotech Incorporated Physically modified extracellular matrix materials and uses thereof
AU2009259835B2 (en) 2008-06-20 2014-02-20 Cook Biotech Incorporated Composite extracellular matrix materials and medical products formed therefrom
WO2023191898A1 (en) * 2022-03-30 2023-10-05 Yale University Method and compositions for treatment, amelioration, and/or prevention of diffuse idiopathic skeletal hyperostosis (dish)
KR20230141227A (ko) * 2022-03-31 2023-10-10 (주)케어젠 항염증 및 항섬유화 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ314680A (en) * 1989-05-09 2000-08-25 Ortho Pharma Corp Treating localised infection or inflammation with a therapeutically conjugated chemotactic peptide
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
CA2309639C (en) * 1997-11-13 2010-03-23 John C. Houck Small peptides and methods for treatment of asthma and inflammation

Also Published As

Publication number Publication date
WO2000032217A1 (en) 2000-06-08
MXPA01005600A (es) 2003-07-14
EP1152770A1 (en) 2001-11-14
HK1044468A1 (zh) 2002-10-25
KR20010108002A (ko) 2001-12-07
KR100596136B1 (ko) 2006-07-05
CA2353550A1 (en) 2000-06-08
JP2003504304A (ja) 2003-02-04
BR9816097A (pt) 2002-01-22
CN1341026A (zh) 2002-03-20

Similar Documents

Publication Publication Date Title
US8809281B2 (en) Small peptides and methods for blocking IGE mediated activation of an immune cell
US7402322B2 (en) Methods of treatment for septic shock with urine extract
US20080242837A1 (en) Peptide compositions
AU1801899A (en) Small peptides and methods for treatment of asthma and inflammation
AU3765100A (en) Treatment with small peptides to effect antifibrotic activity
US20040127405A1 (en) Methods for treating lung infections and lung tumors and for treating and preventing lung metastases
JP7492004B2 (ja) 肺疾患を治療するための生物学的ペプチドおよびその適用
MXPA02000531A (es) Peptidos pequenos y metodos para bajar la regulacion de inmunoglobulina e.
AU2004203599A1 (en) Small peptides and methods for downregulation of IgE
AU2007237181A1 (en) Small peptides and methods for downregulation of IgE

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application